HMVSX
Price
$17.99
Change
+$0.09 (+0.50%)
Updated
Oct 8 closing price
Net Assets
1.14B
JVMCX
Price
$28.02
Change
+$0.13 (+0.47%)
Updated
Oct 8 closing price
Net Assets
24.11B
Interact to see
Advertisement

HMVSX vs JVMCX

Header iconHMVSX vs JVMCX Comparison
Open Charts HMVSX vs JVMCXBanner chart's image
Hartford MidCap Value R4
Price$17.99
Change+$0.09 (+0.50%)
VolumeN/A
Net Assets1.14B
JHancock Disciplined Value Mid Cap C
Price$28.02
Change+$0.13 (+0.47%)
VolumeN/A
Net Assets24.11B
HMVSX vs JVMCX Comparison Chart in %
View a ticker or compare two or three
VS
HMVSX vs. JVMCX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVSX is a Hold and JVMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.1B vs. HMVSX (1.14B). HMVSX pays higher dividends than JVMCX: HMVSX (0.48) vs JVMCX (0.00). HMVSX was incepted earlier than JVMCX: HMVSX (15 years) vs JVMCX (14 years). JVMCX (1.86) is less costly to investors than HMVSX (1.18). HMVSX is a more actively managed with annual turnover of: 132.00 vs. JVMCX (49.00). HMVSX has a lower initial minimum investment than JVMCX: HMVSX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -2.65 vs. HMVSX (-8.17). JVMCX return over 5 years is better than : 42.10 vs. HMVSX (31.13).
HMVSXJVMCXHMVSX / JVMCX
Total Expense Ratio1.181.8564%
Annual Report Gross Expense Ratio1.181.8663%
Fund Existence15 years14 years-
Gain YTD2.46110.23724%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B24.1B5%
Annual Yield % from dividends0.480.00-
Returns for 1 year-8.17-2.65308%
Returns for 3 years9.5525.8237%
Returns for 5 years31.1342.1074%
Returns for 10 years15.5640.8138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CASBF6.99N/A
N/A
CANSINO BIOLOGICS INC
ECNLF1.82N/A
N/A
Aquafil S.P. A
APLO42.20N/A
N/A
Apollo Bancorp, Inc.
MAKSF4.51N/A
N/A
Marks & Spencer Group Plc
ENFD6.00N/A
N/A
ENERGYFUNDERS YIELD FD I LLC